Global Anticoagulants (Xarelto, Eliquis, Pradaxa and Savaysa) Market to 2024 Featuring Key Players - Bayer, BMS/Pfizer, Boehringer Ingelheim and Daiichi Sankyo

DUBLIN, Sept. 18, 2020 /PRNewswire/ -- The "Global Anticoagulants Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024 Edition)" report has been added to ResearchAndMarkets.com's offering.

Bayer Group, BMS/Pfizer, Boehringer Ingelheim and Daiichi Sankyo are some of the key players operating in the global anticoagulants market, who's Company Profiles has been done in the report. This segment summarizes business overview, financial overview and the business strategies of the companies.

The report also provides an analysis of injectable and oral anticoagulants available in the market. Details of Lovenox, Arixtra, Xarelto, Eliquis, Pradaxa and Savaysa has been provided in the report in terms of their global sales. A brief analysis of the US anticoagulants market has also been provided in terms of value and sales of top four oral anticoagulant drugs in the region.

The most commonly prescribed anticoagulant is Warfarin. Newer types of anticoagulants are also available and are becoming increasingly common. These include rivaroxaban (Xarelto), dabigatran (Pradaxa), apixaban (Eliquis), and edoxaban (Savaysa/Lixiana). Warfarin and the newer alternatives are taken as tablets or capsules. There's also an anticoagulant called heparin that can be given by injection.

The global anticoagulants market has increased over the years and is expected to grow during the forecasted years i.e., 2020-2024. The global anticoagulants market is supported by various growth drivers such as growing geriatric population, rising global healthcare expenditure, increasing diabetic population, escalating number of cancer patients, the rising prevalence of cardiovascular disease, etc.

Yet, the market faces some challenges which are obstructing the growth of the market. Some of the challenges are numerous clinical limitations and bleeding risk.

Furthermore, the report also assesses the key opportunities available in the market and outline the market dynamics that are and will be accountable for the growth of the industry. Growth of the global anticoagulants market has also been forecasted for the period 2020-2024, taking into consideration previous growth outlines, growth drivers and the existing and forthcoming trends.

Key Topics Covered:

1. Executive Summary

2. Introduction
2.1 Overview of Anticoagulants
2.1.1 Types of Anticoagulants
2.1.2 Novel Oral Anticoagulants

3. Global Market Analysis
3.1 Global Anticoagulants Market Analysis
3.1.1 Global Anticoagulants Market by Value
3.1.2 Global Anticoagulants Market by Countries (The US and ROW)
3.1.3 Global Anticoagulants Market Share by Segment (Oral Anticoagulants and Other)
3.1.4 Global Anticoagulants Market Share by Products (Eliquis, Xarelto, Pradaxa, Lovenox, Savaysa, Arxitra and other)

4. Global Anticoagulants Product Analysis
4.1 Oral Anticoagulants Product Analysis
4.1.1 Global Oral Anticoagulants Market by Value
4.1.2 Global Xarelto Market by Value
4.1.3 Global Xarelto Market Value by Region
4.1.4 Global Eliquis Market by Value
4.1.5 Global Pradaxa Market by Value
4.1.6 Global Savaysa Market by Value
4.2 Injectable Anticoagulants Product Analysis
4.2.1 Global Lovenox Market by Value
4.2.2 Global Arixtra Market by Value

5. Region/Country Analysis
5.1 The US Anticoagulants Market Analysis
5.1.1 The US Anticoagulants Market by Value
5.1.2 The US Anticoagulants Market by Products (Xarelto, Eliquis, Pradaxa and Savaysa)
5.1.3 The US Xarelto Market by Value
5.1.4 The US Eliquis Market by Value
5.1.5 The US Pradaxa Market by Value
5.1.6 The US Savaysa Market by Value

6. COVID-19
6.1 Impact of Covid-19
6.2 Response of Industry to Covid-19
6.3 Variation in Organic Traffic
6.4 Global Number of COVID-19 Active Cases

7. Market Dynamics
7.1 Growth Drivers
7.1.1 Growth in Geriatric Population
7.1.2 Rising Global Healthcare Expenditure
7.1.3 Increasing Diabetic Population
7.1.4 Escalating Number of Cancer Patients
7.1.5 Rising Prevalence of Cardiovascular Disease
7.1.6 Surging Obese Population
7.2 Challenges
7.2.1 Numerous Clinical Limitation
7.2.2 Bleeding Risk
7.3 Market Trends
7.3.1 Rising Prevalence of Venous Thromboembolism (VTE)
7.3.2 Direct Oral Anticoagulants (DOACs)

8. Competitive Landscape
8.1 Global Anticoagulants Market Players: A Financial Comparison
8.2 Global Anticoagulants Market Players by Product Comparison

9. Company Profiles
9.1 Business Overview
9.2 Financial Overview
9.3 Business Strategy

• Bayer Group
• BMS/Pfizer
• Boehringer Ingelheim
• Daiichi Sankyo

For more information about this report visit https://www.researchandmarkets.com/r/diwudo

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-anticoagulants-xarelto-eliquis-pradaxa-and-savaysa-market-to-2024-featuring-key-players---bayer-bmspfizer-boehringer-ingelheim-and-daiichi-sankyo-301133968.html

SOURCE Research and Markets